Related Experiment Video
Updated: Oct 25, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
Cell therapy strategies for COVID-19: Current approaches and potential applications
Mark M Zaki1,2, Emal Lesha1,3, Khaled Said4
1GC Therapeutics Inc., Cambridge, MA 02139, USA.
Insights
Severe COVID-19 requires better treatments beyond current options. Cell therapies show promise for managing severe COVID-19 and its long-term effects, with 89 trials underway.
Area of Science:
- Immunology
- Regenerative Medicine
- Virology
Background:
- Coronavirus disease 2019 (COVID-19) presents a global health challenge.
- Severe COVID-19 cases exhibit multi-organ involvement and limited therapeutic options.
- Existing treatments lack specificity and do not address long-term sequelae like organ damage.
Purpose of the Study:
- To review COVID-19 pathogenesis and its systemic effects.
- To identify potential applications of cell therapies in severe COVID-19.
- To summarize the landscape of ongoing cell therapy clinical trials for COVID-19.
Main Methods:
- Literature review of COVID-19 pathogenesis.
- Analysis of cell therapy mechanisms and potential benefits.
- Compilation and summary of registered clinical trials for COVID-19 cell therapies.
Main Results:
- COVID-19 impacts multiple organ systems beyond the lungs.
- Cell therapies offer customizable and regenerative approaches for severe disease.
- As of January 1, 2021, 89 cell therapy trials for COVID-19 were identified.
Conclusions:
- Cell therapies represent a promising therapeutic strategy for severe COVID-19.
- Further research and clinical trials are crucial to establish efficacy.
- Addressing long-term consequences of COVID-19 is a key area for cell therapy intervention.
Abstract:
Coronavirus disease 2019 (COVID-19) continues to burden society worldwide. Despite most patients having a mild course, severe presentations have limited treatment options. COVID-19 manifestations extend beyond the lungs and may affect the cardiovascular, nervous, and other organ systems. Current treatments are nonspecific and do not address potential long-term consequences such as pulmonary fibrosis, demyelination, and ischemic organ damage. Cell therapies offer great potential in treating severe COVID-19 presentations due to their customizability and regenerative function. This review summarizes COVID-19 pathogenesis, respective areas where cell therapies have potential, and the ongoing 89 cell therapy trials in COVID-19 as of 1 January 2021.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Related Concept Videos
Tumor Immunotherapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mesenchymal Stem Cells
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...